Larken Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LARKEN LABS INC, and what generic and branded alternatives to LARKEN LABS INC drugs are available?
LARKEN LABS INC has three approved drugs.
Drugs and US Patents for Larken Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Larken Labs Inc | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 201270-001 | Jul 17, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Larken Labs Inc | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | acetaminophen; caffeine; dihydrocodeine bitartrate | TABLET;ORAL | 204209-001 | Sep 30, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Larken Labs Inc | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 203484-002 | Dec 4, 2015 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.